Medical News

RSS

Improving quality of life after breast cancer treatment

Opting for less damaging treatments, staying active and learning about the warning signs of lymphedema: that's how women with breast cancer can avoid developing chronic lymphedema, according to the German Institute for Quality and Efficiency in Health Care (IQWiG).

7 Nov 2008

How RNA polymerase kick starts gene activation revealed

How 'molecular machines' inside cells swing into action to activate genes at different times in a cell's life is revealed in new research published in Molecular Cell.

7 Nov 2008

Anti-herpes drug acyclovir inhibits HIV replication, but with a price

The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC.

7 Nov 2008

Growth hormone treatment helps short children grow up

Growth hormone treatment may significantly increase final height in children diagnosed with short stature, even in cases where the child is not growth hormone deficient, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

7 Nov 2008

Caesarean sections do not reduce hepatitis C transmission

Planned Caesarean sections do not help to reduce the chances of a pregnant mother with Hepatitis C (HCV) transmitting the infection to her unborn baby, according to new scientific findings by the National Maternity Hospital in Dublin and University College Dublin.

7 Nov 2008

For African Americans with hypertensive nephrosclerosis, end stage renal disease risks exceed risk of death from heart disease

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD).

7 Nov 2008

FDA seizes Heparin from Cincinnati manufacturer

As part of the U.S. Food and Drug Administration's ongoing efforts to ensure that heparin for patients remains safe, the government today seized 11 lots of heparin from Celsus Laboratories Inc. in Cincinnati, Ohio.

7 Nov 2008

FDA approves Ranexa for the treatment of chronic angina

CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa(R) (ranolazine extended-release tablets) for the treatment of chronic angina.

7 Nov 2008

Dermatitis management

Although the variety of substances that can cause contact dermatitis is almost limitless, it often can be effectively managed with the proper diagnosis and treatment according to investigators presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle.

7 Nov 2008

Solutions to inequities in kidney transplant allocation

Depending on where they live in the United States, patients needing a kidney transplant can wait just one year for a deceased donor's kidney or up to 10 years.

7 Nov 2008

Experts discuss future of public health research on Down syndrome

Down syndrome, the most commonly identified cause of cognitive impairment, occurs in approximately 1-in-700 births in the United States.

7 Nov 2008

Prevalence of metabolic syndrome and associated risk factors in Illinois

Adopting daily exercise sessions and a calcium-rich diet could reduce the risk of a group of health risk factors called the metabolic syndrome, finds a new study of Illinois adults.

7 Nov 2008

ERSD, heart disease and African-Americans with hypertensive nephrosclerosis

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD).

7 Nov 2008

Efficacy, dosage concerns unresolved on sublingual immunotherapy

Although sublingual immunotherapy (SLIT) is used in Europe and other countries, experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle say questions remain unanswered regarding its effectiveness, appropriate use, dosage, and safety of administration.

7 Nov 2008